SCHEMBL689557

SCHEMBL689557

O=C1N[CH]NC(=O)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alloxan SCHEMBL64547 0.56 MAPT (1.00) —
SCHEMBL3626475 0.56 — —
Alloxan SCHEMBL17364338 0.54 KDM4E (0.92) —
SCHEMBL2489548 0.54 — —
SCHEMBL625895 0.54 — —
Alloxan SCHEMBL20262969 0.54 KDM4E (0.92) —
Alloxan SCHEMBL9093366 0.54 KDM4E (0.92) —
Alloxan SCHEMBL8924365 0.54 KDM4E (0.92) —
SCHEMBL8723031 0.52 — —
SCHEMBL12433546 0.50 KDM4E (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1953148-B1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2012-02-29 — — EP disclosed
US-7915267-B2 Heterocyclic amide compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-29 — — US disclosed
US-20090137603-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-05-28 — — US disclosed
EP-1953148-A1 HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2008-08-06 — — EP disclosed
Send feedback